BODI vs MAX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 26, 2026
BODI
MAX
Investment Advisor Scores
MAX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BODI | MAX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 27.6243 | 11.236 | MAX |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -25.0% | 17.3% | MAX |
| Earnings Growth | 0.0% | 1412.2% | MAX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 54.2/100 | 52.4/100 | BODI |
| Profit Margin | 2.2% | 3.4% | MAX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BODI
DistributionPrice near a flattening SMA50 (slope -10.0%) with fading momentum, RSI 45
MAX
MarkupPrice above SMA50, rising 50-day trend (19.3% over 20 days), RSI 50
Fundamentals Snapshot
| Metric | BODI | MAX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.4 | 8.0 |
| Trailing P/E | 14.1 | 21.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.3% | 0.2% |
| Gross Margin | 0.7% | 0.1% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 0.71 | 0.63 |
| Dividend Yield | — | — |